Copyright
©2011 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Sep 16, 2011; 3(9): 171-182
Published online Sep 16, 2011. doi: 10.4253/wjge.v3.i9.171
Published online Sep 16, 2011. doi: 10.4253/wjge.v3.i9.171
Table 8 Radiofrequency ablation randomized, prospective and sham-control trial[113]
| Study characteristics | Radiofrequency ablation group | Sham group | P value |
| n = 127 Dysplastic Barrett’s esophagus patients | 84 | 43 | - |
| Complete regression of intestinal metaplasia | 77.4% | 2.3% | < 0.001 |
| Complete regression of low grade dysplasia | 90.5% | 22.7% | < 0.001 |
| Complete regression of high grade dysplasia | 81.0% | 19.0% | < 0.001 |
| Global progression rate | 3.6% | 16.3% | < 0.05 |
| Progression to cancer rate | 1.2% | 9.3% | < 0.05 |
- Citation: Ortiz-Fernández-Sordo J, Parra-Blanco A, García-Varona A, Rodríguez-Peláez M, Madrigal-Hoyos E, Waxman I, Rodrigo L. Endoscopic resection techniques and ablative therapies for Barrett’s neoplasia. World J Gastrointest Endosc 2011; 3(9): 171-182
- URL: https://www.wjgnet.com/1948-5190/full/v3/i9/171.htm
- DOI: https://dx.doi.org/10.4253/wjge.v3.i9.171